Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916 - Hussain, M; Goldman, B; Tangen, C (J Clin Oncol, 2009)
et al.